Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market, Industry Trends and Global Forecasts to 2035: ...

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last ...

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Royal Philips (PHG) and Medtronic Neurovascular announced a strategic advocacy partnership. As leaders in stroke diagnosis and treatment, the ...

Medtronic PLC investors have been content with receiving dividends on their holdings for a few years now. The stock has ...

Both companies also join the newly established World Stroke Organization Advocacy Coalition Amsterdam, the Netherlands - Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, and ...

Patients urged to carry extra batteries as Medtronic recall affects 24,595 insulin pumps that may stop delivering insulin ...